These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 21708485)

  • 41.
    Jagadeb M; Rath SN; Sonawane A
    J Biomol Struct Dyn; 2019 Aug; 37(13):3388-3398. PubMed ID: 30132739
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Secretome profile analysis of multidrug-resistant, monodrug-resistant and drug-susceptible Mycobacterium tuberculosis.
    Putim C; Phaonakrop N; Jaresitthikunchai J; Gamngoen R; Tragoolpua K; Intorasoot S; Anukool U; Tharincharoen CS; Phunpae P; Tayapiwatana C; Kasinrerk W; Roytrakul S; Butr-Indr B
    Arch Microbiol; 2018 Mar; 200(2):299-309. PubMed ID: 29119205
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hybrid Design of Isonicotinic Acid Hydrazide Derivatives: Machine Learning Studies, Synthesis and Biological Evaluation of their Antituberculosis Activity.
    Kovalishyn V; Hodyna D; Sinenko VO; Blagodatny V; Semenyuta I; Slivchuk SR; Brovarets V; Poda G; Metelytsia L
    Curr Drug Discov Technol; 2020; 17(3):365-375. PubMed ID: 30973110
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis.
    Zumla A; Rao M; Dodoo E; Maeurer M
    BMC Med; 2016 Jun; 14():89. PubMed ID: 27301245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Individualized Treatment of Multidrug-resistant Tuberculosis Using Whole-Genome Sequencing and Expanded Drug-Susceptibility Testing.
    Dookie N; Padayatchi N; Lessells RJ; Naicker CL; Chotoo S; Naidoo K
    Clin Infect Dis; 2020 Dec; 71(11):2981-2985. PubMed ID: 32384148
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tuberculosis drug resistance mutation database.
    Sandgren A; Strong M; Muthukrishnan P; Weiner BK; Church GM; Murray MB
    PLoS Med; 2009 Feb; 6(2):e2. PubMed ID: 19209951
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibitors of an essential mycobacterial cell wall lipase (Rv3802c) as tuberculosis drug leads.
    West NP; Cergol KM; Xue M; Randall EJ; Britton WJ; Payne RJ
    Chem Commun (Camb); 2011 May; 47(18):5166-8. PubMed ID: 21384024
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of Polymorphisms Associated with Multidrug-Resistant Tuberculosis by Whole Genomic Sequencing: A Preliminary Report from Mexico.
    Zenteno-Cuevas R; Fernandez E; Viveros D; Madrazo-Moya CF; Cancino-Muñoz I; Comas I; Gonzalez-Covarrubias V; Barbosa-Amezcua M; Cuevas-Cordoba B
    Microb Drug Resist; 2020 Jul; 26(7):732-740. PubMed ID: 31874045
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Beyond multidrug resistance: Leveraging rare variants with machine and statistical learning models in Mycobacterium tuberculosis resistance prediction.
    Chen ML; Doddi A; Royer J; Freschi L; Schito M; Ezewudo M; Kohane IS; Beam A; Farhat M
    EBioMedicine; 2019 May; 43():356-369. PubMed ID: 31047860
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Screening of antitubercular compound library identifies novel shikimate kinase inhibitors of Mycobacterium tuberculosis.
    Rajput VS; Mehra R; Kumar S; Nargotra A; Singh PP; Khan IA
    Appl Microbiol Biotechnol; 2016 Jun; 100(12):5415-26. PubMed ID: 26887318
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 2-Alkoxycarbonylaminopyridines: inhibitors of Mycobacterium tuberculosis FtsZ.
    White EL; Suling WJ; Ross LJ; Seitz LE; Reynolds RC
    J Antimicrob Chemother; 2002 Jul; 50(1):111-4. PubMed ID: 12096015
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives.
    Rattan A; Kalia A; Ahmad N
    Emerg Infect Dis; 1998; 4(2):195-209. PubMed ID: 9621190
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Direct inhibitors of InhA are active against Mycobacterium tuberculosis.
    Manjunatha UH; S Rao SP; Kondreddi RR; Noble CG; Camacho LR; Tan BH; Ng SH; Ng PS; Ma NL; Lakshminarayana SB; Herve M; Barnes SW; Yu W; Kuhen K; Blasco F; Beer D; Walker JR; Tonge PJ; Glynne R; Smith PW; Diagana TT
    Sci Transl Med; 2015 Jan; 7(269):269ra3. PubMed ID: 25568071
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reappraising the use of β-lactams to treat tuberculosis.
    Kurz SG; Bonomo RA
    Expert Rev Anti Infect Ther; 2012 Sep; 10(9):999-1006. PubMed ID: 23106275
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discordance across Phenotypic and Molecular Methods for Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates in a Low TB Incidence Country.
    Ahmad S; Mokaddas E; Al-Mutairi N; Eldeen HS; Mohammadi S
    PLoS One; 2016; 11(4):e0153563. PubMed ID: 27096759
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Routine Culture-Resistant Mycobacterium tuberculosis Rescue and Shell-Vial Assay, France.
    Fellag M; Saad J; Armstrong N; Chabrière E; Eldin C; Lagier JC; Drancourt M
    Emerg Infect Dis; 2019 Nov; 25(11):2131-2133. PubMed ID: 31625862
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Collaborative Approach for "ReSeq-ing" Mycobacterium tuberculosis Drug Resistance: Convergence for Drug and Diagnostic Developers.
    Schito M; Dolinger DL
    EBioMedicine; 2015 Oct; 2(10):1262-5. PubMed ID: 26629499
    [No Abstract]   [Full Text] [Related]  

  • 60. Pathogen-based precision medicine for drug-resistant tuberculosis.
    Gröschel MI; Walker TM; van der Werf TS; Lange C; Niemann S; Merker M
    PLoS Pathog; 2018 Oct; 14(10):e1007297. PubMed ID: 30335850
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.